2022 - Research.com Medicine in Israel Leader Award
Moussa B.H. Youdim mainly focuses on Neuroprotection, Pharmacology, Biochemistry, Oxidative stress and Dopamine. The Neuroprotection study combines topics in areas such as Neurotoxicity, Antioxidant, Parkinson's disease, MPTP and Catechin. His Pharmacology study incorporates themes from Anesthesia, Selegiline, Monoamine oxidase B, Rasagiline and Polyphenol.
The various areas that Moussa B.H. Youdim examines in his Biochemistry study include Chelation and Amyloid precursor protein. His Oxidative stress study integrates concerns from other disciplines, such as Iron Chelating Agents, Reactive oxygen species, Neurodegeneration, Alzheimer's disease and Biological activity. Endocrinology and Internal medicine are the areas that his Dopamine study falls under.
His main research concerns Pharmacology, Neuroprotection, Internal medicine, Endocrinology and Monoamine oxidase. His studies deal with areas such as Neurotrophic factors, Selegiline, Monoamine oxidase B, MPTP and Rasagiline as well as Pharmacology. His Neuroprotection study combines topics in areas such as Oxidative stress, Biochemistry, Neurodegeneration and Parkinson's disease.
The concepts of his Endocrinology study are interwoven with issues in Receptor and Binding protein. His biological study spans a wide range of topics, including Tyramine, Cholinesterase and Serotonin. His Neuroscience research incorporates elements of Alzheimer's disease and Disease.
His primary areas of investigation include Neuroprotection, Pharmacology, Oxidative stress, Neuroscience and Monoamine oxidase. His Neuroprotection research integrates issues from Neurodegeneration, Parkinson's disease, Disease, Rasagiline and Amyloid precursor protein. His Neurodegeneration research is classified as research in Internal medicine.
Moussa B.H. Youdim has included themes like Neurotrophic factors, Dopamine, Monoamine oxidase B and Monoamine oxidase inhibitor in his Pharmacology study. His Oxidative stress research entails a greater understanding of Biochemistry. His study explores the link between Monoamine oxidase and topics such as Ladostigil that cross with problems in Protein kinase A.
His primary areas of study are Neuroprotection, Pharmacology, Monoamine oxidase, Oxidative stress and Rasagiline. His Neuroprotection research includes elements of Biochemistry, Amyloid precursor protein, Ladostigil, Dopamine and Animal data. His study in Pharmacology is interdisciplinary in nature, drawing from both Neurotrophic factors, Dementia, Monoamine oxidase B and Monoamine oxidase inhibitor.
His research in Monoamine oxidase intersects with topics in Antidepressant and In vitro. His Oxidative stress research is multidisciplinary, incorporating elements of Neurotoxicity and Iron Chelating, Antioxidant. His Rasagiline research is multidisciplinary, incorporating perspectives in Selegiline and Protein kinase C.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.
Peter Riederer;Emin Sofic;Wolf-Dieter Rausch;Bruno Schmidt.
Journal of Neurochemistry (1989)
Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases
M. Gerlach;D. Ben-Shachar;P. Riederer;M. B. H. Youdim.
Journal of Neurochemistry (2002)
Oxidative stress: Free radical production in neural degeneration
Mario E. Götz;Gabriella Künig;Peter Riederer;Moussa B.H. Youdim.
Pharmacology & Therapeutics (1994)
Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration.
Yona Levites;Orly Weinreb;Gila Maor;Moussa B. H. Youdim.
Journal of Neurochemistry (2001)
Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.
E. Sofic;W. Paulus;K. Jellinger;P. Riederer.
Journal of Neurochemistry (1991)
Brain iron and ferritin in Parkinson's and Alzheimer's diseases.
K. Jellinger;W. Paulus;I. Grundke-Iqbal;P. Riederer.
Journal of Neural Transmission - Parkinson's Disease and Dementia Section (1990)
Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study.
W. Birkmayer;J. Knoll;P. Riederer;M. B. H. Youdim.
Journal of Neural Transmission (1985)
Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases
Orly Weinreb;Silvia Mandel;Tamar Amit;Moussa B.H. Youdim.
Journal of Nutritional Biochemistry (2004)
The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil.
W. Birkmayer;P. Riederer;M. B. H. Youdim;W. Linauer.
Journal of Neural Transmission (1975)
Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases.
Silvia Mandel;Moussa B.H Youdim.
Free Radical Biology and Medicine (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: